ATE238417T1
(de)
|
1991-11-04 |
2003-05-15 |
Inst Genetics Llc |
Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
|
US6607884B1
(en)
|
1993-03-19 |
2003-08-19 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-8
|
US7393682B1
(en)
*
|
1993-03-19 |
2008-07-01 |
The Johns Hopkins University School Of Medicine |
Polynucleotides encoding promyostatin polypeptides
|
US5994618A
(en)
|
1997-02-05 |
1999-11-30 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 transgenic mice
|
US20030074680A1
(en)
*
|
1993-03-19 |
2003-04-17 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
CA2157577C
(en)
*
|
1993-03-19 |
2009-11-17 |
Se-Jin Lee |
Growth differentiation factor-8
|
US7566768B1
(en)
|
1995-10-26 |
2009-07-28 |
The Johns Hopkins University School Of Medicine |
Promyostatin peptides and methods of using same
|
US6465239B1
(en)
|
1993-03-19 |
2002-10-15 |
The John Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species
|
EP2272959A1
(en)
|
1993-05-12 |
2011-01-12 |
Genetics Institute, LLC |
BMP-11 compositions
|
US6713302B1
(en)
|
1993-07-09 |
2004-03-30 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-6
|
US7332575B2
(en)
*
|
1994-03-18 |
2008-02-19 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
|
WO1996001845A1
(en)
*
|
1994-07-08 |
1996-01-25 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-11
|
US20030167492A1
(en)
|
1994-07-08 |
2003-09-04 |
Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
|
US6008434A
(en)
|
1994-07-08 |
1999-12-28 |
Johns Hopkins University School Of Medicine |
Growth differentiation factor-11 transgenic mice
|
US5846770A
(en)
*
|
1994-11-22 |
1998-12-08 |
Genetics Institute, Inc. |
DNA molecules encoding human chordin
|
US5635372A
(en)
*
|
1995-05-18 |
1997-06-03 |
Genetics Institute, Inc. |
BMP-15 compositions
|
HU222664B1
(hu)
|
1995-06-05 |
2003-09-29 |
Genetics Institute, Llc |
Csont morfogenetikus protein (BMP) alkalmazása csont és ín vagy szalag funkcionális összeköttetésének regenerálására
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
US5965403A
(en)
*
|
1996-09-18 |
1999-10-12 |
Genetics Institute, Inc. |
Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
EP0985149A1
(en)
|
1997-05-30 |
2000-03-15 |
Creative Biomolecules, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
US20070067859A1
(en)
*
|
1997-07-14 |
2007-03-22 |
Michel Georges |
Double-muscling in mammals
|
EP2045322B1
(en)
*
|
1997-07-14 |
2015-07-01 |
Université de Liège |
Double-muscling in mammals
|
US6103466A
(en)
*
|
1997-07-14 |
2000-08-15 |
University Of Liege |
Double-muscling in mammals
|
US6891082B2
(en)
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
US6656475B1
(en)
|
1997-08-01 |
2003-12-02 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
|
US6696260B1
(en)
*
|
1997-08-01 |
2004-02-24 |
The Johns Hopkins University School Of Medicine |
Methods to identify growth differentiation factor (GDF) binding proteins
|
US20020052026A1
(en)
|
1997-10-08 |
2002-05-02 |
Steven M. Vicik |
Methods of refolding proteins
|
US6027917A
(en)
|
1997-12-10 |
2000-02-22 |
Genetics Institute, Inc. |
Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
|
WO1999040181A1
(en)
*
|
1998-02-05 |
1999-08-12 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-8
|
US6369201B1
(en)
|
1998-02-19 |
2002-04-09 |
Metamorphix International, Inc. |
Myostatin multimers
|
US6004937A
(en)
*
|
1998-03-09 |
1999-12-21 |
Genetics Institute, Inc. |
Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
|
EP1075272B1
(en)
*
|
1998-05-06 |
2009-07-15 |
Metamorphix, Inc. |
Methods for treating diabetes by inhibiting gdf-8
|
US7147839B2
(en)
|
1998-05-29 |
2006-12-12 |
Curis, Inc. |
Methods for evaluating tissue morphogenesis and activity
|
ES2318900T3
(es)
*
|
1998-07-15 |
2009-05-01 |
Metamorphix, Inc. |
Promotor del factor de diferenciacion del crecimiento y sus usos.
|
CN100567322C
(zh)
*
|
1999-01-21 |
2009-12-09 |
梅塔莫菲克斯公司 |
抑制生长分化因子活性的多肽及表达该多肽的细胞
|
US6727224B1
(en)
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US6284882B1
(en)
*
|
1999-06-10 |
2001-09-04 |
Abbott Laboratories |
Myostatin gene promoter and inhibition of activation thereof
|
ZA200003786B
(en)
|
1999-07-30 |
2002-01-21 |
Pfizer Prod Inc |
Myostatin regulatory region, nucleotide sequence determination and methods for its use.
|
US6756215B1
(en)
*
|
2000-10-20 |
2004-06-29 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Functionalized TGF-β fusion proteins
|
US7037501B2
(en)
*
|
2001-01-04 |
2006-05-02 |
Regents Of The University Of Minnesota |
Myostatin immnoconjugate
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
KR100420798B1
(ko)
*
|
2001-02-10 |
2004-03-02 |
(주)알에이싸이언스 |
펩타이드 벡터
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
US6798160B2
(en)
*
|
2001-11-02 |
2004-09-28 |
Honda Giken Kogyo Kabushiki Kaisha |
Electric working machine
|
JP4429728B2
(ja)
|
2002-02-21 |
2010-03-10 |
ワイス エルエルシー |
フォリスタチン(follistatin)ドメイン含有タンパク質
|
AU2003217612A1
(en)
*
|
2002-02-21 |
2003-09-09 |
Wyeth |
GASP1: a follistatin domain containing protein
|
MXPA05002968A
(es)
*
|
2002-09-16 |
2005-09-08 |
Univ Johns Hopkins |
Activacion de miostatina por metaloproteasa, y metodos de modular la actividad de miostatina.
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
DE60335915D1
(de)
|
2002-12-20 |
2011-03-10 |
Amgen Inc |
Myostatin hemmende bindungsstoffe
|
RU2322261C2
(ru)
|
2003-06-02 |
2008-04-20 |
Уайт |
Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний
|
EP1675608B1
(en)
|
2003-09-12 |
2007-03-21 |
Wyeth |
Injectable calcium phosphate solid rods for delivery of osteogenic proteins
|
BRPI0418317A
(pt)
*
|
2003-12-31 |
2007-05-02 |
Schering Plough Ltd |
vacina de aumento de crescimento à base de epitopo de neutralização
|
ES2350939T3
(es)
|
2004-03-10 |
2011-01-28 |
Scil Technology Gmbh |
Implantes recubiertos, su fabricación y uso de los mismos.
|
US20070178095A1
(en)
*
|
2004-03-23 |
2007-08-02 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
JP4688483B2
(ja)
*
|
2004-04-15 |
2011-05-25 |
株式会社テクノネットワーク四国 |
フォリスタチン変異体ポリペプチド
|
US7575751B2
(en)
|
2004-04-27 |
2009-08-18 |
Research Development Foundation |
Activin-A mutants
|
CA2567405A1
(en)
|
2004-05-25 |
2005-12-08 |
Stryker Corporation |
Use of morphogenic proteins for treating cartilage defects
|
EP1778275A2
(en)
*
|
2004-08-12 |
2007-05-02 |
Wyeth |
Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
WO2006073827A2
(en)
*
|
2004-12-30 |
2006-07-13 |
Schering-Plough Ltd. |
Neutralizing epitope-based growth enhancing vaccine
|
WO2006081379A1
(en)
*
|
2005-01-26 |
2006-08-03 |
Wyeth |
Use of sfrps as markers of bmp activity
|
ES2852549T3
(es)
|
2005-02-09 |
2021-09-13 |
Sarepta Therapeutics Inc |
Composición antisentido para tratamiento de la atrofia muscular
|
CN101137906A
(zh)
*
|
2005-03-23 |
2008-03-05 |
惠氏公司 |
对gdf-8调节剂的免疫应答的检测
|
US20060239951A1
(en)
*
|
2005-03-30 |
2006-10-26 |
Alexandre Valentin |
Methods for stimulating hair growth by administering BMPs
|
CN103450359B
(zh)
|
2005-08-19 |
2018-07-24 |
惠氏有限责任公司 |
抗gdf-8的拮抗剂抗体以及在als和其他gdf-8-相关病症治疗中的用途
|
BRPI0616923A2
(pt)
*
|
2005-10-06 |
2011-07-05 |
Lilly Co Eli |
anticorpos monoclonais, seus usos e composição farmacêutica
|
UA92504C2
(en)
*
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
CA2632544C
(en)
*
|
2005-12-06 |
2014-09-23 |
Amgen Inc. |
Use of myostatin antagonist for treating the effects of hypogonadism
|
WO2007092622A2
(en)
|
2006-02-09 |
2007-08-16 |
Biomimetic Therapeutics, Inc. |
Compositions and methods for treating bone
|
EP2006381B1
(en)
|
2006-03-31 |
2016-02-03 |
Chugai Seiyaku Kabushiki Kaisha |
Method for controlling blood pharmacokinetics of antibodies
|
US20090298761A1
(en)
|
2006-05-17 |
2009-12-03 |
Donald Engelman |
Methods of treating cartilage defects using a soluble morphogenic protein complex
|
US9161967B2
(en)
|
2006-06-30 |
2015-10-20 |
Biomimetic Therapeutics, Llc |
Compositions and methods for treating the vertebral column
|
JP5484047B2
(ja)
|
2006-06-30 |
2014-05-07 |
バイオミメティック セラピューティクス, エルエルシー |
回旋筋腱板傷害を処置するためのpdgf−生体マトリックス組成物および方法
|
US8524265B2
(en)
|
2006-08-17 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Medical implant sheets useful for tissue regeneration
|
JP5058261B2
(ja)
*
|
2006-09-05 |
2012-10-24 |
イーライ リリー アンド カンパニー |
抗ミオスタチン抗体
|
AU2007234612B2
(en)
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
JP5452230B2
(ja)
|
2006-12-21 |
2014-03-26 |
ストライカー コーポレイション |
生物学的因子の結晶、高分子ゲルおよび粒子懸濁液を含む持続放出処方物
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
TW201718635A
(zh)
|
2007-03-06 |
2017-06-01 |
安美基公司 |
變異之活動素受體多肽及其用途
|
US8236751B2
(en)
*
|
2007-03-07 |
2012-08-07 |
The Johns Hopkins University |
Methods of increasing muscle mass using follistatin-like related gene (FLRG)
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
JP2010535708A
(ja)
|
2007-08-03 |
2010-11-25 |
ビオマリン アイジーエー リミテッド |
デュシェンヌ型筋ジストロフィーの治療のための薬物併用
|
EP2187932B1
(en)
|
2007-08-07 |
2015-01-28 |
DePuy Synthes Products, LLC |
Protein formulations comprising gdf-5 in aqueous acidic solution
|
PL2202245T3
(pl)
|
2007-09-26 |
2017-02-28 |
Chugai Seiyaku Kabushiki Kaisha |
Sposób modyfikowania punktu izoelektrycznego przeciwciała poprzez podstawienie aminokwasu w cdr
|
AU2009214629A1
(en)
|
2008-02-13 |
2009-08-20 |
Eric T. Choi |
BMP-7 for use in treating vascular sclerosis
|
US8461108B2
(en)
|
2008-03-07 |
2013-06-11 |
Myoscience, Inc. |
Subdermal tissue remodeling using myostatin, methods and related systems
|
ES2563483T3
(es)
|
2008-04-11 |
2016-03-15 |
Chugai Seiyaku Kabushiki Kaisha |
Molécula de unión a antígeno capaz de unirse repetidamente a dos o más moléculas de antígeno
|
CA2720845A1
(en)
|
2008-04-14 |
2009-10-22 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered gdf-5 formulations
|
BRPI0918611B8
(pt)
|
2008-09-09 |
2021-06-22 |
Biomimetic Therapeutics Inc |
composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
|
NZ627111A
(en)
|
2008-11-26 |
2015-10-30 |
Amgen Inc |
Variants of activin iib receptor polypeptides and uses thereof
|
UY32341A
(es)
|
2008-12-19 |
2010-07-30 |
Glaxo Group Ltd |
Proteínas de unión antígeno novedosas
|
US20100204124A1
(en)
|
2009-02-12 |
2010-08-12 |
Mary Elizabeth Pecquet Goad |
Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
|
AU2010213575B2
(en)
|
2009-02-12 |
2013-11-14 |
Stryker Corporation |
Peripheral administration of proteins including TGF-beta superfamily members for systemic treatment of disorders and disease
|
WO2010110974A1
(en)
|
2009-03-24 |
2010-09-30 |
Stryker Corporation |
Methods and compositions for tissue engineering
|
US8609127B2
(en)
|
2009-04-03 |
2013-12-17 |
Warsaw Orthopedic, Inc. |
Medical implant with bioactive material and method of making the medical implant
|
WO2010144696A1
(en)
|
2009-06-11 |
2010-12-16 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
US20110224138A1
(en)
|
2009-09-09 |
2011-09-15 |
Julie Krop |
Methods for treating pain induced by injuries and diseases of an articular joint
|
EP2352750B1
(en)
|
2009-09-17 |
2012-06-13 |
Stryker Corporation |
Buffers for controlling the ph of bone morphogenetic proteins
|
EP2516456A1
(en)
|
2009-12-22 |
2012-10-31 |
Stryker Corporation |
Bmp-7 variants with reduced immunogenicity
|
CN107080834A
(zh)
|
2010-02-22 |
2017-08-22 |
生物模拟治疗有限责任公司 |
用于治疗腱病的血小板衍生生长因子组合物和方法
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
KR20140005864A
(ko)
|
2010-08-16 |
2014-01-15 |
암젠 인코퍼레이티드 |
미오스타틴에 결합하는 항체, 조성물 및 방법
|
KR101800596B1
(ko)
|
2010-08-20 |
2017-11-22 |
와이어쓰 엘엘씨 |
디자이너 골형성 단백질
|
US9688735B2
(en)
|
2010-08-20 |
2017-06-27 |
Wyeth Llc |
Designer osteogenic proteins
|
US20140234340A1
(en)
|
2010-11-30 |
2014-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
AU2012339722B2
(en)
|
2011-11-14 |
2017-09-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and/or Activin A
|
MX358358B
(es)
|
2011-12-19 |
2018-08-15 |
Amgen Inc |
Polipeptidos de receptores de activina variantes y sus usos.
|
JP6433889B2
(ja)
|
2012-06-15 |
2018-12-05 |
ファイザー・インク |
Gdf−8に対する改善された拮抗抗体およびその使用
|
US10034945B2
(en)
|
2012-07-13 |
2018-07-31 |
Trustees Of Tufts College |
Silk powder compaction for production of constructs with high mechanical strength and stiffness
|
CA2880649C
(en)
|
2012-08-01 |
2023-03-14 |
Elizabeth MCNALLY |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
|
WO2014030750A1
(ja)
|
2012-08-24 |
2014-02-27 |
中外製薬株式会社 |
マウスFcγRII特異的Fc抗体
|
CA2882272C
(en)
|
2012-08-24 |
2023-08-29 |
Chugai Seiyaku Kabushiki Kaisha |
Fc.gamma.riib-specific fc region variant
|
DK3564258T3
(da)
|
2012-09-13 |
2021-06-21 |
Bristol Myers Squibb Co |
Fibronektinbaserede skeletdomæneproteiner, der binder til myostatin
|
CN105431455A
(zh)
|
2013-02-01 |
2016-03-23 |
圣塔玛丽亚生物疗法公司 |
抗激活素a化合物对受试者的施用
|
EP2982689B1
(en)
|
2013-04-02 |
2020-08-26 |
Chugai Seiyaku Kabushiki Kaisha |
Fc region variant
|
SG10201800800YA
(en)
|
2013-05-06 |
2018-03-28 |
Scholar Rock Inc |
Compositions and methods for growth factor modulation
|
TW201920262A
(zh)
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素a之抗體及其用途
|
EP3215175A4
(en)
|
2014-11-06 |
2018-06-27 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
WO2016073906A2
(en)
*
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Transforming growth factor-related immunoassays
|
SG11201700841QA
(en)
|
2014-12-19 |
2017-03-30 |
Chugai Pharmaceutical Co Ltd |
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
|
CN107108729A
(zh)
|
2015-02-05 |
2017-08-29 |
中外制药株式会社 |
包含离子浓度依赖性的抗原结合结构域的抗体,fc区变体,il‑8‑结合抗体,及其应用
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
EA201792298A1
(ru)
|
2015-04-15 |
2018-04-30 |
Регенерон Фармасьютикалз, Инк. |
Способы увеличения силы и функциональности с помощью ингибиторов gdf8
|
KR20230155021A
(ko)
|
2015-09-15 |
2023-11-09 |
스칼러 락, 인크. |
항-프로/잠재성-미오스타틴 항체 및 그의 용도
|
CN108699555A
(zh)
|
2015-10-09 |
2018-10-23 |
萨勒普塔医疗公司 |
用于治疗杜兴肌营养不良和相关病症的组合物和方法
|
US10780171B2
(en)
|
2015-10-26 |
2020-09-22 |
President And Fellows Of Harvard College |
Reduced and oxidized polysaccharides and methods of use thereof
|
JP7141336B2
(ja)
|
2015-12-25 |
2022-09-22 |
中外製薬株式会社 |
抗ミオスタチン抗体および使用方法
|
WO2017120523A2
(en)
|
2016-01-08 |
2017-07-13 |
Scholar Rock, Inc. |
Anti-pro/latent myostatin antibodies and methods of use thereof
|
PE20190205A1
(es)
|
2016-06-13 |
2019-02-07 |
Scholar Rock Inc |
Uso de inhibidores de miostatina y terapias de combinacion
|
TWI611811B
(zh)
|
2016-06-17 |
2018-01-21 |
中外製藥股份有限公司 |
抗肌抑素抗體及使用方法
|
CA3026050A1
(en)
|
2016-08-05 |
2018-02-08 |
Chugai Seiyaku Kabushiki Kaisha |
Composition for prophylaxis or treatment of il-8 related diseases
|
SI3565592T1
(sl)
|
2017-01-06 |
2023-05-31 |
Scholar Rock, Inc. |
Zdravljenje presnovnih bolezni z zaviranjem aktivacije miostatina
|
MA52417A
(fr)
|
2018-03-01 |
2021-01-06 |
Regeneron Pharma |
Procédés de modification de composition corporelle
|
JP2022512346A
(ja)
|
2018-12-18 |
2022-02-03 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
レプチン受容体、gdf8、およびアクチビンaに対するアンタゴニストを使用して、体重および除脂肪筋肉量を増やすための組成物および方法
|
US20220143136A1
(en)
|
2018-12-21 |
2022-05-12 |
Northwestern University |
Use of annexins in preventing and treating muscle membrane injury
|
US20220062299A1
(en)
|
2018-12-26 |
2022-03-03 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
JP7375525B2
(ja)
*
|
2019-12-23 |
2023-11-08 |
株式会社島津製作所 |
患者認証システムおよび患者認証方法
|
JP7397822B2
(ja)
*
|
2021-05-14 |
2023-12-13 |
花王株式会社 |
口腔用貼付シート
|
US20240199728A1
(en)
|
2022-09-21 |
2024-06-20 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating obesity, diabetes, and liver dysfunction
|
WO2024107652A1
(en)
*
|
2022-11-14 |
2024-05-23 |
John Mansell |
Myostatin inhibition
|